The CB2R–OX2R heteromer as a new therapeutic target to combat Alzheimer’s disease
Summary of the work awarded with the first prize of the First edition of the UB Dr. Antoni i Subirana Chair Award for Research in Pharmacology for the best Master's Degree in Research in Pharmacology at the University of Barcelona
| Autor: | |
|---|---|
| Formato: | informe técnico |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:dnet:recercat____::58332d75ac22461fe6887e107453de02 |
| Acesso em linha: | https://hdl.handle.net/2445/228684 |
| Access Level: | acceso abierto |
| Palavra-chave: | Malaltia d'Alzheimer Farmacologia Alzheimer's disease Pharmacology |
| Resumo: | Summary of the work awarded with the first prize of the First edition of the UB Dr. Antoni i Subirana Chair Award for Research in Pharmacology for the best Master's Degree in Research in Pharmacology at the University of Barcelona |
|---|